drugset / Trial / NCT00676377

A New Approach of Neostigmine in Unavoidable Post Operative Ileus

NCT00676377

Phase 4 Completed 3 enrolled Baqiyatallah Medical Sciences University
RandomizedParallel-groupTriple-blindSupportive care

Summary

Postoperative ileus (POI) in the absence of any mechanical obstruction remains a commonly encountered clinical problem.So, this study aimed to show the effective way to decrease the rate of postoperative Ileus (POI).

Timeline

Start
2007-08
Primary completion
2007-12
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Neostigmine Other / unclassified 2.5 mg Intravenous

Indications